Cantharidin Alters the Expression of Genes Associated with the NKG2D-associated Immune Response in TSGH-8301 Human Bladder Carcinoma Cells.

Jehn-Hwa Kuo,An-Cheng Huang,Jen-Jyh Lin,Kuang-Chi Lai,Rick Sai-Chuen Wu,Jiun-Long Yang,Bin-Chuan Ji,Mei-Due Yang,Yung-Lin Chu,Jing-Gung Chung
DOI: https://doi.org/10.3892/ol.2017.6168
2017-01-01
Oncology Letters
Abstract:Cantharidin (CTD) is a natural toxin in beetles of the Mylabris genus (blister beetle), which has been revealed to induce cell death in various types of human cancer cells. However, to the best of our knowledge, no previous studies have investigated the effect of CTD on the expression of genes and their associated signaling pathways in human bladder carcinoma cells. In the present study, CTD-induced cell morphological changes and apoptosis were observed using phase-contrast microscopy and the terminal deoxynucleotidyl transferase dUTP nick end labeling assay, respectively, in TSGH-8301 human bladder carcinoma cells. In addition, a complementary DNA microarray analysis demonstrated that CTD treatment led to a >2-fold upregulation of 269 genes. For example, the DNA damage-associated gene DNA-damage-inducible transcript 3 had a 4.75-fold upregulation. Furthermore, another 286 genes were >2-fold downregulated in response to CTD treatment. Matrix-remodeling associated 5, which is associated with cell migration and invasion, was downregulated 7.98-fold.
What problem does this paper attempt to address?